|
1
|
Thai AA, Solomon BJ, Sequist LV, Gainor JF
and Heist RS: Lung cancer. Lancet. 398:535–554. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miller M and Hanna N: Advances in systemic
therapy for non-small cell lung cancer. BMJ. 9:n23632021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meyer ML, Fitzgerald BG, Paz-Ares L,
Cappuzzo F, Jänne PA, Peters S and Hirsch FR: New promises and
challenges in the treatment of advanced non-small-cell lung cancer.
Lancet. 404:803–822. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Remon J, Soria JC and Peters S; ESMO
Guidelines Committee. Electronic address, : simpleclinicalguidelines@esmo.org:
Early and locally advanced non-small-cell lung cancer: An update of
the ESMO clinical practice guidelines focusing on diagnosis,
staging, systemic and local therapy. Ann Oncol. 32:1637–1642. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao YW, Liu S, Qin H, Sun JB, Su M, Yu
GJ, Zhou J, Gao F, Wang RY, Zhao T and Zhao GS: Efficacy and safety
of CalliSpheres drug-eluting beads for bronchial arterial
chemoembolization for refractory non-small-cell lung cancer and its
impact on quality of life: A multicenter prospective study. Front
Oncol. 13:11109172023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zha B, Zhang Y, Yang R and Kamili M:
Efficacy and safety of anlotinib as a third-line treatment of
advanced non-small cell lung cancer: A meta-analysis of randomized
controlled trials. Oncol Lett. 24:2292022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kou F, Gao S, Liu S, Wang X, Chen H, Zhu
X, Guo J, Zhang X, Feng A and Liu B: Preliminary clinical efficacy
of iodine-125 seed implantation for the treatment of advanced
malignant lung tumors. J Cancer Res Ther. 15:1567–1573. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He G, Yang K, Zhang X, Pan J, Han A, Gao
Z, Li Y and Wang W: Bronchial artery chemoembolization with
drug-eluting beads versus bronchial artery infusion followed by
polyvinyl alcohol particles embolization for advanced squamous cell
lung cancer: A retrospective study. Eur J Radiol. 161:1107472023.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Du L and Morgensztern D: Chemotherapy for
advanced-stage non-small cell lung cancer. Cancer J. 21:366–370.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Komada T, Suzuki K, Mizuno T, Ebata T,
Matsushima M, Naganawa S and Nagino M: Efficacy of percutaneous
transhepatic portal vein embolization using gelatin sponge
particles and metal coils. Acta Radiol Open.
7:20584601187696872018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu H, Zheng C, Liang B and Xiong B:
Quantitative splenic embolization possible: Application of 8Spheres
conformal microspheres in partial splenic embolization (PSE). BMC
Gastroenterol. 21:4072021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Detterbeck FC, Chansky K, Groome P,
Bolejack V, Crowley J, Shemanski L, Kennedy C, Krasnik M, Peake M,
Rami-Porta R, et al: The IASLC lung cancer staging project:
Methodology and validation used in the development of proposals for
revision of the stage classification of NSCLC in the forthcoming
(eighth) edition of the TNM classification of lung cancer. J Thorac
Oncol. 11:1433–1446. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the eastern cooperative oncology group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Asano R, Kajimoto K, Oka T, Sugiura R,
Okada H, Kamishima K, Hirata T and Sato N; investigators of the
Acute Decompensated Heart Failure Syndromes (ATTEND) registry, :
Association of New York Heart Association functional class IV
symptoms at admission and clinical features with outcomes in
patients hospitalized for acute heart failure syndromes. Int J
Cardiol. 230:585–591. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ettinger DS, Wood DE, Aisner DL, Akerley
W, Bauman J, Chirieac LR, D'Amico TA, DeCamp MM, Dilling TJ,
Dobelbower M, et al: Non-small cell lung cancer, version 5.2017,
NCCN clinical practice guidelines in oncology. J Natl Compr Canc
Netw. 15:504–535. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Atkinson TM, Ryan SJ, Bennett AV, Stover
AM, Saracino RM, Rogak LJ, Jewell ST, Matsoukas K, Li Y and Basch
E: The association between clinician-based common terminology
criteria for adverse events (CTCAE) and patient-reported outcomes
(PRO): A systematic review. Support Care Cancer. 24:3669–3676.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fan Z, Yang LC, Chen YQ, Wan WQ, Zhou DH,
Mai HR, Li WL, Yang LH, Lan HK, Chen HQ, et al: Prognostic
significance of MRD and its correlation with arsenic concentration
in pediatric acute promyelocytic leukemia: A retrospective study by
SCCLG-APL group. Ther Adv Hematol. 16:204062072413117742025.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chaft JE, Shyr Y, Sepesi B and Forde PM:
Preoperative and postoperative systemic therapy for operable
non-small-cell lung cancer. J Clin Oncol. 40:546–555. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chin J, Rumble RB, Kollmeier M, Heath E,
Efstathiou J, Dorff T, Berman B, Feifer A, Jacques A and Loblaw DA:
Brachytherapy for patients with prostate cancer: American society
of clinical oncology/cancer care ontario joint guideline update. J
Clin Oncol. 35:1737–1743. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sharma R, Sagoo NS, Haider AS, Sharma N,
Haider M, Sharma IK, Igbinigie M, Aya KL, Aoun SG and Vira S:
Iodine-125 radioactive seed brachytherapy as a treatment for spine
and bone metastases: A systematic review and meta-analysis. Surg
Oncol. 38:1016182021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cheng G, Wang Y, Dong D, Zhang W, Wang L
and Wan Z: To evaluate the efficacy and safety of 125I seed
implantation in SCLC as second line therapy. Medicine (Baltimore).
101:e292512022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sui A, Song H, Yu H, Zhang H, Hu Q, Lei Y,
Zhang L and Wang J: Clinical application of iodine-125 seed
brachytherapy combined with anti-PD-1 antibodies in the treatment
of lung cancer. Clin Ther. 42:1612–1616. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Z, Hu Z, Xiong X and Song X: A review
of the efficacy and safety of iodine-125 seed implantation for lung
cancer treatment. Cancer Treat Res Commun. 41:1008442024.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma X, Zheng D, Zhang J, Dong Y, Li L, Jie
B and Jiang S: Clinical outcomes of vinorelbine loading
CalliSpheres beads in the treatment of previously treated advanced
lung cancer with progressive refractory obstructive atelectasis.
Front Bioeng Biotechnol. 10:10882742022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu J, Xu X, Chen Y, Wang Q, Yue Q, Lei K,
Jia Y, Xiao G and Xu G: Bronchial artery chemoembolization with
apatinib for treatment of central lung squamous cell carcinoma. J
Cancer Res Ther. 18:1432–1435. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Luz JHM, Gomes FV, Coimbra E, Costa NV and
Bilhim T: Preoperative portal vein embolization in hepatic surgery:
A review about the embolic materials and their effects on liver
regeneration and outcome. Radiol Res Pract.
2020:92958522020.PubMed/NCBI
|
|
28
|
Liu J, Shi D, Li L, Cao L, Liu J, He J and
Liang Z: Clinical study on the treatment of benign prostatic
hyperplasia by embolization of prostate artery based on embosphere
microspheres and gelatin sponge granules. J Healthc Eng.
2022:14240212022.PubMed/NCBI
|
|
29
|
Zhang Y, Xu Y, Zhang X, Zheng B, Hu W,
Yuan G and Si G: 8Spheres conformal microspheres as embolic agents
for symptomatic uterine leiomyoma therapy in uterine artery
embolization (UAE): A prospective clinical trial. Medicine
(Baltimore). 102:e330992023. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou J, Feng Z, Liu S, Li X, Liu Y, Gao F,
Shen J, Zhang YW, Zhao GS and Zhang M: Simultaneous CSM-TACE with
CalliSpheres® and partial splenic embolization using
8spheres® for hepatocellular carcinoma with
hypersplenism: Early prospective multicenter clinical outcome.
Front Oncol. 12:9985002022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chao Y, Wu CY, Kuo CY, Wang JP, Luo JC,
Kao CH, Lee RC, Lee WP and Li CP: Cytokines are associated with
postembolization fever and survival in hepatocellular carcinoma
patients receiving transcatheter arterial chemoembolization.
Hepatol Int. 7:883–892. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Takaki H, Hirata Y, Ueshima E, Kodama H,
Matsumoto S, Wada R, Suzuki H, Nakasho K and Yamakado K: Hepatic
artery embolization enhances expression of programmed cell death 1
ligand 1 in an orthotopic rat hepatocellular carcinoma model: In
vivo and in vitro experimentation. J Vasc Interv Radiol.
31:1475–1482.e2. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kang F, Wu J, Hong L, Zhang P and Song J:
Iodine-125 seed inhibits proliferation and promotes apoptosis of
cholangiocarcinoma cells by inducing the ROS/p53 axis. Funct Integr
Genomics. 24:1142024. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen C, Wang W, Yu Z, Tian S, Li Y and
Wang Y: Combination of computed tomography-guided iodine-125
brachytherapy and bronchial arterial chemoembolization for locally
advanced stage III non-small cell lung cancer after failure of
concurrent chemoradiotherapy. Lung Cancer. 146:290–296. 2020.
View Article : Google Scholar : PubMed/NCBI
|
